Serum Insulin-Like Growth Factor-1 in Parkinson's Disease; Study of Cerebrospinal Fluid Biomarkers and White Matter Microstructure

Background: Growing evidence shows that impaired signaling of Insulin-like Growth Factor-1 (IGF-1) is associated with neurodegenerative disorders, such as Parkinson's disease (PD). However, there is still controversy regarding its proinflammatory or neuroprotective function. In an attempt to el...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Endocrinol (Lausanne)
Autors principals: Ghazi Sherbaf, Farzaneh, Mohajer, Bahram, Ashraf-Ganjouei, Amir, Mojtahed Zadeh, Mahtab, Javinani, Ali, Sanjari Moghaddam, Hossein, Shirin Shandiz, Mehdi, Aarabi, Mohammad Hadi
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2018
Matèries:
Endocrinology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6224341/
https://ncbi.nlm.nih.gov/pubmed/30450079
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2018.00608
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars